eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 19/01/2012
PIL Telfast 30mg tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 10/01/2011 and displayed until 19/01/2012
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 07/05/2009 and displayed until 10/01/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 08/06/2004 and displayed until 07/05/2009
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 22/08/2003 and displayed until 08/06/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   fexofenadine hydrochloride